ZILRETTA Trademark

Trademark Overview

On Tuesday, January 20, 2015, a trademark application was filed for ZILRETTA with the United States Patent and Trademark Office. The USPTO has given the ZILRETTA trademark a serial number of 86508900. The federal status of this trademark filing is REGISTERED as of Tuesday, February 13, 2018. This trademark is owned by Flexion Therapeutics, Inc.. The ZILRETTA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for managing and relieving pain and inflammation; pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; analgesic and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for injection for medical purposes for the treatment of musculoskeletal conditions, soft tissue conditions and arthritis
zilretta

General Information

Serial Number86508900
Word MarkZILRETTA
Filing DateTuesday, January 20, 2015
Status700 - REGISTERED
Status DateTuesday, February 13, 2018
Registration Number5401949
Registration DateTuesday, February 13, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 30, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for managing and relieving pain and inflammation; pharmaceutical preparations for use in the treatment of musculoskeletal conditions, soft tissue conditions, and arthritis; analgesic and anti-inflammatory pharmaceutical preparations; pharmaceutical preparations for injection for medical purposes for the treatment of musculoskeletal conditions, soft tissue conditions and arthritis
Translation of Words in MarkThe wording "ZILRETTA" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 31, 2015
Primary Code005
First Use Anywhere DateTuesday, October 31, 2017
First Use In Commerce DateTuesday, October 31, 2017

Trademark Owner History

Party NameFlexion Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803
Party NameFlexion Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803
Party NameFlexion Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBurlington, MA 01803

Trademark Events

Event DateEvent Description
Monday, February 12, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, April 19, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, February 13, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 9, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 26, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, October 15, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 15, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, February 13, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, January 11, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, January 10, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, January 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 8, 2018STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 3, 2018USE AMENDMENT FILED
Monday, January 8, 2018SOU EXTENSION 5 GRANTED
Wednesday, January 3, 2018SOU EXTENSION 5 FILED
Wednesday, January 3, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, January 3, 2018TEAS STATEMENT OF USE RECEIVED
Tuesday, August 29, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 25, 2017SOU EXTENSION 4 GRANTED
Friday, August 25, 2017SOU EXTENSION 4 FILED
Friday, August 25, 2017SOU TEAS EXTENSION RECEIVED
Wednesday, March 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 27, 2017SOU EXTENSION 3 GRANTED
Monday, February 27, 2017SOU EXTENSION 3 FILED
Monday, February 27, 2017SOU TEAS EXTENSION RECEIVED
Thursday, September 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 14, 2016SOU EXTENSION 2 GRANTED
Wednesday, August 24, 2016SOU EXTENSION 2 FILED
Wednesday, September 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, August 24, 2016SOU TEAS EXTENSION RECEIVED
Friday, February 26, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 24, 2016SOU EXTENSION 1 GRANTED
Wednesday, February 24, 2016SOU EXTENSION 1 FILED
Wednesday, February 24, 2016SOU TEAS EXTENSION RECEIVED
Tuesday, August 25, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 30, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 30, 2015PUBLISHED FOR OPPOSITION
Wednesday, June 10, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 22, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, May 20, 2015ASSIGNED TO LIE
Monday, April 27, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, April 27, 2015EXAMINER'S AMENDMENT ENTERED
Monday, April 27, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, April 27, 2015EXAMINERS AMENDMENT E-MAILED
Monday, April 27, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, April 24, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 24, 2015NON-FINAL ACTION E-MAILED
Friday, April 24, 2015NON-FINAL ACTION WRITTEN
Thursday, April 23, 2015ASSIGNED TO EXAMINER
Saturday, January 31, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, January 23, 2015NEW APPLICATION ENTERED

Related Keywords

zilretta preparations pharmaceutical conditions musculoskeletal tissue arthritis treatment soft inflammatory injection